Getinge part of EU project to develop artificial placenta for neonatales
Despite big medical progress in the past 50 years, a high number of neonatal deaths occur every year. A consortium with members from academia and industry, including Getinge, have now received funding to develop an artificial placenta to keep supporting lung and kidney function development after birth – in an attempt to save the lives of more premature newborns. The placenta is a temporary organ that develops in the uterus during pregnancy. While the baby is still in the womb, the placenta provides it with nutrients and oxygen while removing waste products from the blood.